This is a new core facility established at the request of the Cancer Center membership at the 1998 leadership retreat. The Cancer Center Executive Committee recommended that we enter into a partnership with the Doheny Eye Institute to jointly purchase a 5th generation confocal microscope to be housed in their space under the direction of Dr. Hinton. The Doheny Eye Institute is located next door to the Norris building which gives members easy access to an already functional facility containing an existing older back-up confocal microscope. The Center committed $250,000 of philanthropic funds to the new instrument and expects to utilize the joint facility approximately 50% of the time. The Executive Committee felt that this approach would give the membership immediate access to state-of-the-art imaging. Also located within the 2,000 square foot core facility, in addition to the two confocals, are the following shared instruments whose use is charged back to investigators on a cost recovery basis: one transmission electron microscope (Zeiss EM-10B), one scanning electron microscope with digital capture and computer workstation (Hitachi S-570), three ultra microtomes, three darkrooms for developing, printing and autoradiography, a photomicroscopy and photomicrography imaging suite complete with a Spot II digital camera and computer imaging system adapted to two Olympus Microphot scopes with Nomarski and phase optics, one Olympus inverted microscope with fluorescence and phase optics, one Zeiss fluorescence microscope with phase, darkfield, and differential interference contrast optics, and digital camera copy stand. Other equipment located in the facility includes a vacuum evaporator, sputter coater, critical point dryer, two print processors, three enlargers, two print and film dryers, two dissecting microscopes, a tissue cryostat, tissue chopper, several computer workstations, a Polaroid slide maker, a color laser printer and a slide scanner. The Confocal Core Facility is currently operating at 90% capacity and has proved to be an invaluable resource for over 20 cancer center members in a wide range of programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA014089-27S1
Application #
6577731
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-04-02
Project End
2002-11-30
Budget Start
Budget End
Support Year
27
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Ricker, Charité N; Koff, Rachel B; Qu, Chenxu et al. (2018) Patient communication of cancer genetic test results in a diverse population. Transl Behav Med 8:85-94
Valentin-Torres, Alice; Savarin, Carine; Barnett, Joslyn et al. (2018) Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation. J Neuroinflammation 15:121
Tobin, Jessica; Miller, Kimberly A; Baezconde-Garbanati, Lourdes et al. (2018) Acculturation, Mental Health, and Quality of Life among Hispanic Childhood Cancer Survivors: A Latent Class Analysis. Ethn Dis 28:55-60
Jayne, Jordanna G; Bensman, Timothy J; Schaal, Justin B et al. (2018) Rhesus ?-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment. Am J Respir Cell Mol Biol 58:310-319
Lee, Brian H; Stallcup, Michael R (2018) Different chromatin and DNA sequence characteristics define glucocorticoid receptor binding sites that are blocked or not blocked by coregulator Hic-5. PLoS One 13:e0196965
Harris, Holly R; Babic, Ana; Webb, Penelope M et al. (2018) Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 27:174-182
Woodham, Andrew W; Cheloha, Ross W; Ling, Jingjing et al. (2018) Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses. Cancer Immunol Res 6:870-880
Matsusaka, S; Wu, A H; Cao, S et al. (2018) Prognostic impact of FOXF1 polymorphisms in gastric cancer patients. Pharmacogenomics J 18:262-269
Vannini, Ivan; Fanini, Francesca; Fabbri, Muller (2018) Emerging roles of microRNAs in cancer. Curr Opin Genet Dev 48:128-133
Veyseh, Maedah; Ricker, Charite; Espenschied, Carin et al. (2018) Secondary Germline Finding in Liquid Biopsy of a Deceased Patient; Case Report and Review of the Literature. Front Oncol 8:259

Showing the most recent 10 out of 842 publications